Home / Recalls / Aurolife Pharma, LLC / D-0877-2023

D-0877-2023 Class III Terminated

Recalled by Aurolife Pharma, LLC — Dayton, NJ

FDA drug recall D-0877-2023 was initiated by Aurolife Pharma, LLC on May 18, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Aug 28, 2024).

Recall Details

Product Type: Drugs
Report Date: Jun 28, 2023
Initiation Date: May 18, 2023
Termination Date: Aug 28, 2024

Product Description

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 01421038A1, Exp. Date 05/2023

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0877-2023
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Aurolife Pharma, LLC

D-0087-2023 Class II — Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by… (Dec 16, 2022)
D-0736-2022 Class II — Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by… (Mar 17, 2022)
D-1869-2019 Class II — Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate… (Aug 23, 2019)
D-1870-2019 Class II — Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons… (Aug 23, 2019)
D-1874-2019 Class II — Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons… (Aug 23, 2019)
D-1873-2019 Class II — Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons… (Aug 23, 2019)
D-1866-2019 Class II — Allergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton… (Aug 23, 2019)
D-1865-2019 Class II — Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a)… (Aug 23, 2019)
D-1864-2019 Class II — Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed… (Aug 23, 2019)
D-1867-2019 Class II — fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark… (Aug 23, 2019)